CDC and FDA recommend US pause use of Johnson & Johnson's Covid-19 vaccine over blood clot concerns
deleted.com
The US Centers for Disease Control and Prevention and the US Food and Drug Administration are recommending that the United States pause the use of Johnson & Johnson's Covid-19 vaccine over six reported US cases of a "rare and severe" type of blood clot. The six reported cases were among more than 6.8 million doses of the Johnson & Johnson vaccine administered in the United States. All six cases occurred among women ages of 18 and 48, and symptoms occurred 6 to 13 days after vaccination, according to a joint statement on Tuesday from Dr. Anne Schuchat, principal deputy director of the CDC and Dr. Peter Marks, director of the FDA's Center for Biologics Evaluation and Research.

Permanently Deleted

  • livingperson2 [he/him]
    ·
    3 years ago

    It doesn't matter anyway. Didn't you all know that vaccines only reduce the severity of symptoms, but don't decrease the chance of catching the disease? My psychiatrist told me so about 2 hours ago.

    • space_comrade [he/him]
      ·
      3 years ago

      Which is super fucking fine. The point is to keep people out of hospitals, not keeping people from getting the sniffles.

      • truth [they/them]
        ·
        3 years ago

        Yes, but when you have the sniffles, you can still get people sick and put them in the hospital. That's what people around here (Midwest usa, not hexbear) seem to be in denial about.

    • CommCat [none/use name]
      ·
      3 years ago

      the first shot is around only 50% effective, but should be near 100% effective in preventing severe symptoms. After the 2nd shot, it should be above 90% in preventing COVID-19. My parents are scheduled for the pfizer/moderna vaccine and that's what the official claims are.